Laflunimus, CAS [[147076-36-6]]

Produktübersicht

• Artikelname: Laflunimus, CAS [[147076-36-6]]
• Artikelnummer: MCE-HY-101813
• Hersteller Artikelnummer: HY-101813
• Alternativnummer: MCE-HY-101813-10MMX1ML,MCE-HY-101813-100MG,MCE-HY-101813-50MG,MCE-HY-101813-5MG,MCE-HY-101813-10MG,MCE-HY-101813-25MG
• Hersteller: MedchemExpress
• Kategorie: Biochemikalien
• Alternative Synonym: HR325

Produktbeschreibung

Laflunimus (HR325) is an immunosuppressive agent and an analogue of the Leflunomide-active metabolite A77 1726. Laflunimus is an orally active inhibitor of dihydroorotate dehydrogenase (DHODH). Laflunimus suppresses immunoglobulin (Ig) secretion, with IC50 values of 2.5 and 2 µM for IgM and IgG, respectively. Laflunimus also is a prostaglandin endoperoxide H synthase (PGHS) -1 and -2 inhibitor[1][2].

Produkteigenschaften

• Molekulargewicht: 310.27
• Reinheit: 99.70
• CAS Nummer: [147076-36-6]
• Formel: C15H13F3N2O2
• Target-Kategorie: Dihydroorotate Dehydrogenase,DNA/RNA Synthesis,Prostaglandin Receptor

Anwendungsbeschreibung

• Anwendungsbeschreibung: MCE Product type: Reference compound